Diagnosis of primary aldosteronism: For medical management, not just surgery

Journal of Hypertension

Volumn 27, Issue 1, 2009, Pages 204-205

  Spence, J David ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALISKIREN; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; EPLERENONE; RENIN; SPIRONOLACTONE;

AFRICAN AMERICAN; APPARENT MINERALOCORTICOID EXCESS SYNDROME; DRUG CONTRAINDICATION; DRUG MEGADOSE; GYNECOMASTIA; HUMAN; HYPERTENSION; LETTER; LIDDLE SYNDROME; MASTALGIA; NEGRO; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; STROKE; TREATMENT CONTRAINDICATION; UNNECESSARY PROCEDURE; HYPERALDOSTERONISM; NOTE;

HUMANS; HYPERALDOSTERONISM;

EID: 58849121432     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32831b7687     Document Type: Letter

References (9)

1. Kaplan NM. Primary aldosteronism: an update on screening, diagnosis and treatment. J Hypertens 2008; 26:1708-1709.
2. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117:e25-e146.
3. Baker EH, Duggal A, Dong Y, Ireson NJ,WoodM,Markandu ND,MacGregor GA. Amiloride, a speci?c drug for hypertension in black people with T594M variant? Hypertension. Hypertension 2002; 40:13-17.
4. Swift PA, MacGregor GA. Genetic variation in the epithelial sodium channel: a risk factor for hypertension in people of African origin. Adv Ren Replace Ther 2004; 11:76-86.
5. Biglieri EG, Kater CE, Arteaga EE. Primary aldosteronism is composed of primary adrenal hyperplasia and adenoma. J Hypertens 1984; 2 (Suppl):S259-S261.
6. Padwal RS, Hemmelgarn BR, McAlister FA, McKay DW, Grover S,Wilson T, et al. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2007; 23:529-538.
7. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scienti?c statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117:e510-e526.
8. Spence JD. Physiologic tailoring of therapy for resistant hypertension: 20 years' experience with stimulated renin pro?ling. Am J Hypertens 1999; 12:1077-1083.
9. Spence JD. The current epidemic of primary aldosteronism: causes and consequences. J Hypertens 2004; 22:2038-2039.